Pre-symptomatic prediction of morbitidies in preterm infants with patent ductus arteriosus by targeted neonatal echocardiography and brain-type natriuretic peptide
Objectives: Our objective was to compare patent ductus arteriosus (PDA) diameter, PDA score and brain-type natriuretic peptide (BNP) measurements at 48-72 hours of life, for prediction of neonatal morbidities. We hypothesized that use of a PDA score with BNP, may improve pre-symptomatic prediction o...
Saved in:
Main Authors: | Yasser Elsayed (Author), Mary Seshia (Author), Reeni Soni (Author), Ilan Buffo (Author), Ronald J. Baier (Author), Patrick J. McNamara (Author), Shyamala Dakshinamurti (Author) |
---|---|
Format: | Book |
Published: |
Hygeia Press di Corridori Marinella,
2016-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serial serum brain-type natriuretic peptide (BNP) identifies compromised blood flow in infants with hemodynamically significant patent ductus arteriosus
by: Yasser Elsayed, et al.
Published: (2017) -
Individualized ibuprofen treatment using serial B-type natriuretic peptide measurement for symptomatic patent ductus arteriosus in very preterm infants
by: Jeonghee Shin, et al.
Published: (2017) -
Symptomatic aneurysm of ductus arteriosus in neonates
by: Nageswara R Koneti, et al.
Published: (2011) -
B-type natriuretic peptide may have a role in the management of patent ductus arteriosus
by: Jang Hoon Lee
Published: (2018) -
Perinatal risk factors of symptomatic preterm patent ductus arteriosus and secondary ligation
by: Jin A Lee, et al.
Published: (2020)